The combination of trifluridine/tipiracil conferred superior overall survival compared with placebo in the third- and fourth-line metastatic gastric cancer treatment settings. This finding, derived from an exploratory subgroup analysis of the TAGS study, was presented at the 2021 Gastrointestinal Cancers Symposium.
A total of 337 patients in the TAGS study’s (ClinicalTrials.gov identifier: NCT02500043) intention-to-treat group had received trifluridine/tipiracil as third- (n=126) or fourth-line (n=211) treatment and were compared with 64 and 106 placebo controls, respectively. Baseline characteristics were well balanced between treatment arms.
The median overall survival (OS) was significantly longer in the active treatment groups compared with the placebo groups. Median OS was 6.8 months for trifluridine/tipiracil vs 3.2 months for placebo (HR, =0.67; 95% CI, 0.47-0.97; P <.05) in the third-line group. It was 5.2 months vs 3.7 months (HR, 0.72; 95% CI, 0.55-0.95; P <.03) in the fourth-line group. The median progression-free survival also was significantly longer in the active treatment groups vs placebo groups (P= .0004 and P <.0001, respectively, for the third- and fourth-line).
Quality-of-life (QOL) results among patients in the subgroup analysis were consistent with those of the overall TAGS study population. No clinically significant deterioration in QoL, as measured by the QLQ-C30 and other subscales, was observed. The frequency of adverse events was similar between the 2 groups as well.
more recommended stories
Kaempferol: A Breakthrough in Allergy ManagementKaempferol, a dietary flavonoid found in.
Early Milk Cereal Drinks May Spur Infant Weight GainNew research published in Acta Paediatrica.
TaVNS: A Breakthrough for Chronic Insomnia TreatmentA recent study conducted by the.
First-of-Its-Kind Gene-Edited Pig Kidney: Towana’s New LifeSurgeons at NYU Langone Health have.
Just-in-Time Training Improves Success & Patient SafetyA study published in The BMJ.
ChatGPT Excels in Medical Summaries, Lacks Field-Specific RelevanceIn a recent study published in.
Study finds automated decision minimizes high-risk medicine combinations in ICU patientsA multicenter study coordinated by Amsterdam.
Study Discovers Connection Between Omicron Infection and Brain Structure Changes in MenA recent study in the JAMA.
Advancing COPD Prognosis: Deep Learning ModelsResearchers conducted a meta-analysis in a.
4 in 1 Test for Swine Flu, COVID-19, RSV, and InfluenzaIn the United Kingdom, the first.
Leave a Comment